---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000054"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T05:04:05.422555+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Chemed Q4 2021 adj EPS $5.25, up 2.3%; VITAS revenue down 4.8%; issues mixed 2022 guidance

## Summary
- Consolidated Q4 revenue $541M (+1.4%); GAAP diluted EPS $4.81; adjusted diluted EPS $5.25 (+2.3%).
- VITAS net revenue $316M (-4.8%), ADC 17,935 (-4.2%), admissions down 9.5%; adjusted EBITDA margin 21.7% (-179 bps).
- Roto-Rooter revenue $225M (+11.8%); adjusted EBITDA $62.2M (+14.2%); margin 27.7% (+58 bps).
- 2022 guidance: adjusted EPS $19.10-$19.50 (vs 2021 $19.33); VITAS revenue down 1.5-2.5%; Roto-Rooter revenue growth 8-9.5%.
- Q4 share repurchases: 495,529 shares for $246M; $202M remaining authorization.

## SEC filing metadata
- accession: 0001562762-22-000054
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000156276222000054/0001562762-22-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000156276222000054/che-20220224x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000054
- JSON: https://secwatch.observer/filing/0001562762-22-000054.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.